Vor Biopharma Inc’s filing revealed that its Director RA CAPITAL MANAGEMENT, L.P. unloaded Company’s shares for reported $6.34 million on Oct 29 ’25. In the deal valued at $25.22 per share,251,518 shares were sold. As a result of this transaction, RA CAPITAL MANAGEMENT, L.P. now holds 804,231 shares worth roughly $7.91 million.
Then, RA CAPITAL MANAGEMENT, L.P. sold 124,311 shares, generating $3,408,230 in total proceeds. Upon selling the shares at $27.42, the Director now owns 1,055,749 shares.
Before that, RA CAPITAL MANAGEMENT, L.P. sold 24,579 shares. Vor Biopharma Inc shares valued at $617,424 were divested by the Director at a price of $25.12 per share. As a result of the transaction, RA CAPITAL MANAGEMENT, L.P. now holds 779,652 shares, worth roughly $7.67 million.
Robert W. Baird upgraded its Vor Biopharma Inc [VOR] rating to an Outperform from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who increased its forecast for the stock in late September from “a Hold” to “a Buy”. H.C. Wainwright also remained covering VOR and has increased its forecast on June 30, 2025 with a “Buy” recommendation from previously “Neutral” rating. Wedbush started covering the stock on July 26, 2022. It rated VOR as “an Outperform”.
Price Performance Review of VOR
On Tuesday, Vor Biopharma Inc [NASDAQ:VOR] saw its stock fall -47.66% to $9.84. Over the last five days, the stock has lost -52.14%. Vor Biopharma Inc shares have fallen nearly -41.01% since the year began. Nevertheless, the stocks have fallen -55.68% over the past one year. While a 52-week high of $65.80 was reached on 07/08/25, a 52-week low of $2.62 was recorded on 05/09/25.
Levels Of Support And Resistance For VOR Stock
The 24-hour chart illustrates a support level at 9.16, which if violated will result in even more drops to 8.47. On the upside, there is a resistance level at 10.37. A further resistance level may holdings at 10.89.
How much short interest is there in Vor Biopharma Inc?
A steep rise in short interest was recorded in Vor Biopharma Inc stocks on 2025-10-31, dropping by -0.44 million shares to a total of 0.91 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 1.35 million shares. There was a decline of -47.77%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on April 27, 2022 when Goldman began covering the stock and recommended ‘”a Neutral”‘ rating along with a $6 price target.
